IRadimed Corporation provided revenue guidance for the third quarter ended September 30, 2022. Third-quarter revenue is expected to be approximately $13.4 million, up 23% from the prior year and above the Company's third-quarter guidance of $13.1 million to $13.3 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.88 USD | -0.61% | -1.88% | -10.01% |
05-02 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.01% | 546M | |
+75.72% | 12.56B | |
-23.98% | 7.47B | |
+8.18% | 6.75B | |
+14.95% | 5.5B | |
-16.30% | 4.94B | |
+30.59% | 4.66B | |
-25.47% | 3.75B | |
-23.60% | 2.92B | |
-2.48% | 1.98B |
- Stock Market
- Equities
- IRMD Stock
- News IRADIMED CORPORATION
- IRadimed Corporation Provides Revenue Guidance for the Third Quarter Ended September 30, 2022